Vol. 51 No. 2 (2012): Acta Oncologica

Articles

• Actinomyces infection mimicking tumor-progression in rectal cancer under neoadjuvant therapy

  Sven Petersen, Florian Würschmidt, Helmut Gaul, Jörg Caselitz, Wolfgang Schwenk

  270-272

  Published: 2012-02-01

  • PDF

• Risk profile of bevacizumab in patients with non-small cell lung cancer: A meta-analysis of randomized controlled trials

  Chao Cao, Jianmiao Wang, Hansvin Bunjhoo, Yongjian Xu, Huijuan Fang

  151-156

  Published: 2012-02-01

  • PDF

• A randomised controlled trial of support group intervention after breast cancer treatment: Results on anxiety and depression

  Helena Granstam Björneklett, Christina Lindemalm, Andreas Rosenblad, Marja-Leena Ojutkangas, Henry Letocha, Peter Strang, Leif Bergkvist

  198-207

  Published: 2012-02-01

  • PDF

• Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers

  Kristoffer S. Rohrberg, René K. Olesen, Per Pfeiffer, Morten Ladekarl, Helle Pappot, Ib J. Christensen, Gunilla Høyer-Hansen, Morten Sørensen, Birgit G. Skov, Ian Buysschaert, Peter Carmeliet, Ulrik Lassen

  234-242

  Published: 2012-02-01

  • PDF

• Muir-Torre syndrome – an uncommon localization of sebaceous carcinomas following irradiation

  Martina Becker-Schiebe, Horst Hannig, Wolfgang Hoffmann, Konrad Donhuijsen

  265-268

  Published: 2012-02-01

  • PDF

• Testicular cancer risk according to county of birth and county of diagnosis in Norway, 1958–2007

  Øivind Kvammen, Steinar Tretli, Tom B. Johannessen, Olbjørn Klepp, Tom Grotmol

  177-184

  Published: 2012-02-01

  • PDF

• Dose prescription and treatment planning based on FMISO-PET hypoxia

  Iuliana Toma-Dasu, Johan Uhrdin, Laura Antonovic, Alexandru Dasu, Sandra Nuyts, Karin Haustermans, Anders Brahme

  222-230

  Published: 2012-02-01

  • PDF

• Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study

  Deirdre P. Cronin-Fenton, Ylva Hellberg, Kristina L. Lauridsen, Thomas P. Ahern, Jens Peter Garne, Carol Rosenberg, Rebecca A. Silliman, Henrik Toft Sørensen, Timothy L. Lash, Stephen Hamilton-Dutoit

  254-261

  Published: 2012-02-01

  • PDF

• Denosumab and the current status of bone-modifying drugs in breast cancer

  Brittany L. Lee, Michaela J. Higgins, Paul E. Goss

  157-167

  Published: 2012-02-01

  • PDF

• Factors affecting participation in group intervention in patients after adjuvant treatment for early-study breast cancer

  Yaira Hamama-Raz, Shlomit Perry, Ruthy Pat-Horenczyk, Ruth Bar-Levav, Solomon M. Stemmer

  208-214

  Published: 2012-02-01

  • PDF

• A curated database of genetic markers from the angiogenesis/VEGF pathway and their relation to clinical outcome in human cancers

  Sevtap Savas

  243-246

  Published: 2012-02-01

  • PDF

• Prostate cancer related haemophagocytic syndrome: Successful treatment with chemotherapy

  Lydie Declerck, Claude Adenis, Eric Amela, Armelle Caty, Antoine Adenis, Nicolas Penel

  268-269

  Published: 2012-02-01

  • PDF

• Testicular germ cell tumours – still many challenges

  Olav Dahl, Marianne Brydøy

  147-150

  Published: 2012-02-01

  • PDF

• Testicular-cancer survivors experience compromised language following chemotherapy: Findings in a Swedish population-based study 3–26 years after treatment

  Johanna Skoogh; Gunnar Steineck, Ulrika Stierner, Eva Cavallin-Ståhl, Ulrica Wilderäng, Anders Wallin, Margaret Gatz, Boo Johansson

  185-197

  Published: 2012-02-01

  • PDF

• Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer

  Finn Ole Larsen, Mogens Karsbøl Boisen, Annelene L. Fromm, Benny Vittrup Jensen

  231-233

  Published: 2012-02-01

  • PDF

• Testicular cancer and the tuberous sclerosis complex

  Torgrim Tandstad, Gunnar Indrebø

  262-265

  Published: 2012-02-01

  • PDF

• High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer – a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA)

  Hege S. Haugnes, Anna Laurell, Ulrika Stierner, Roy M. Bremnes, Olav Dahl, Eva Cavallin-Ståhl, Gabriella Cohn-Cedermark

  168-176

  Published: 2012-02-01

  • PDF

• Adrenal lesions in patients with extra-adrenal malignancy – benign or malignant?

  Lilian Hammarstedt, Andreas Muth, Helga Á. Sigurjónsdóttir, Erik Almqvist, Bo Wängberg, Mikael Hellström

  215-221

  Published: 2012-02-01

  • PDF

• Eligibility, compliance and persistence of extended adjuvant endocrine therapy for breast cancer

  Mary E. Myrick, Seraina M. Schmid, Nerbil Kilic, Uwe Güth

  247-253

  Published: 2012-02-01

  • PDF